ACQUISITIONS and MERGERS
Medical Device News Magazine is the leading resource for medical device M&A information. We provide coverage of all the latest deals, as well as insights and analyses from industry experts.
Our readers rely on us for the most up-to-date information on the medical device market. We are focused on delivering the most comprehensive news coverage possible. Whether you are a CEO, CFO, investor, or employee of a medical device company, MDNM is the source you can trust for all your merger and acquisition news.
INTEGRA Biosciences Acquires Miroculus
This will allow INTEGRA Biosciences to expand its product range for library preparation, offering significant time savings to academic, research, and diagnostics laboratories using NGS and, ultimately, accelerating discovery in this dynamic field.
E Tech Group Acquires E-Volve Systems
E-Volve will operate under the name “E-Volve Systems, an E Tech Group Company.” Kevin Stout and Principals Jason Antolovich, Vivek Puthezath will remain with the company, and no significant employment changes are anticipated in E-Volve’s Merrimack, New Hampshire, or Cincinnati, Ohio, offices.
Olympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd
Taewoong Medical is a Korea-based manufacturer of medical devices such as gastrointestinal (GI) metallic stents[1] to strengthen its GI endotheraphy product portfolio capabilities, and in turn, contributing to improving patient outcome through comprehensive solutions.
Abbott to Acquire Cardiovascular Systems, Inc.
Cardiovascular Systems is a leader in devices for atherectomy, a minimally invasive treatment for plaque build-up in arteries that can restrict blood flow.
Radiant Logic Signs Definitive Agreement to Acquire Brainwave GRC
The acquisition will strengthen both Radiant Logic and Brainwave GRC’s respective market positions as identity, analytics and intelligence experts by offering a new lightweight data-centric governance capability and a market-defining identity data intelligence platform.
Shockwave Medical to Acquire Neovasc
"Today’s announcement is good news for our stakeholders and the Reducer program," said Fred Colen, President and CEO of Neovasc. "We have made tremendous strides building accelerating revenue, clinical data, commercial reimbursement, and a fantastic team, and now it’s time to take the next step to accelerate Reducer adoption globally. The team at Shockwave has demonstrated an extraordinary ability to scale novel technologies and build value for patients, customers and investors, and we are thrilled to become a part of their organization."